by Vindana Chibabhai
Are you looking for a medical podcast covering every day issues in diagnostic tests, antimicrobial therapy and management of infections that is relevant to a low or middle income setting? A show that simplifies complex concepts in an easy to follow conversational format? You've come to the right place. This is Microbe Mail - a medical podcast for the busy practitioner or student covering topics in microbiology, infectious diseases and infection control. Sign up to our newsletter to receive updates on new episode releases at: https://microbemail.captivate.fm/ Contact us at [email protected]
Language
🇺🇲
Publishing Since
8/12/2021
Email Addresses
0 available
Phone Numbers
0 available
April 23, 2025
<p>Dans un monde où une piqûre de moustique peut encore être mortelle, il est réconfortant de savoir que notre mentalité s'oriente désormais vers la prévention et l'élimination. Dans cet épisode, Miriam s'entretient avec le Dr Abdouramane Camara, un lauréat de la Bourse d'accélération de carrière en Afrique et pionnier en immunologie, au sujet des vaccins antipaludiques.</p><p>À propos de notre invité: </p><p>Le Dr Abdouramane Camara est chercheur postdoctoral au West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), à l'Université du Ghana. Après plus de dix ans passés dans plusieurs institutions européennes, il a su forger une solide expertise, le Dr Camara est revenu en Afrique pour contribuer à son avancement scientifique en développant un nouveau test clinique permettant d'évaluer l'efficacité des vaccins à un stade précoce et de prédire la protection à long terme.</p><p>Ses travaux de recherche visent à élucider les mécanismes impliqués dans la génération des plasmocytes à longue durée de vie et des cellules productrices d’anticorps, ainsi qu’à explorer leur capacité à prédire précocement l’efficacité d’une vaccination. Il s'intéresse particulièrement au paludisme, une maladie endémique dans de nombreux pays africains, et à l'efficacité des nouveaux vaccins antipaludiques. Au-delà du paludisme, il étudie également les vaccins procurant une immunité à long terme, voire à vie, afin de contribuer à l'amélioration de la conception et des stratégies de mise en œuvre des vaccins.</p><p><a href="https://www.malariavaccine.org/tools-resources/malaria-parasite-life-cycle" rel="noopener noreferrer" target="_blank">Malaria life cycle: Reproduced from PATH's Malaria Vaccines website at www.malariavaccine.org, 2024</a></p><p><a href="https://www.who.int/teams/global-malaria-programme/elimination#:~:text=As%20of%20January%202025%2C%20a,as%20malaria%2Dfree%20by%20WHO" rel="noopener noreferrer" target="_blank">Global Malaria programme</a></p><p><strong>NOUS AIMERIONS VOTRE AVIS SUR CET ÉPISODE – </strong> </p><p>Visit the Microbe Mail <a href="https://microbemail.captivate.fm/" rel="noopener noreferrer" target="_blank">website</a> to sign up for updates </p><p>Follow on:</p><p><u>Instagram</u>: <a href="https://www.instagram.com/microbe_mail?igsh=MWo4NGVpcDJ4d3M2Zw==" rel="noopener noreferrer" target="_blank">Microbe_Mail</a></p><p><u>X/Twitter</u>: <a href="https://x.com/microbemail?t=DBBAVuqPh9bh7VhrVpKJwA&s=09" rel="noopener noreferrer" target="_blank">@microbemail</a></p><p><u>Facebook</u>: <a href="https://www.facebook.com/microbemail?mibextid=ZbWKwL" rel="noopener noreferrer" target="_blank">MicrobeMail</a></p><p><u>Tiktok:</u> <a href="mailto:https://www.tiktok.com/@microbe.mail?_t=8k6FtWzw2uj&_r=1" rel="noopener noreferrer" target="_blank">@</a><a href="https://vm.tiktok.com/ZMMehs22o/" rel="noopener noreferrer" target="_blank">microbe.mail</a></p><p>Watch this episode on our new <u>YouTube channel</u>: <a href="https://www.youtube.com/@Microbe_mail-YT" rel="noopener noreferrer" target="_blank">Microbe Mail</a></p><p>E-mail us: <a href="mailto:[email protected]" rel="noopener noreferrer" target="_blank">[email protected]</a></p>
April 23, 2025
<p>In a world where a mosquito bite can still be deadly, it is comforting to know that our mindset has shifted towards prevention and elimination. In this episode, Ruan speaks to a fellow recipient of the African Career Acceleration Fellowship,<strong> Dr Abdouramane Camara</strong> who is a pioneer in immunology, about malarial vaccines.</p><p>About our Guest: </p><p><strong>Dr Abdouramane Camara</strong> is a postdoc research fellow at the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana. After spending over a decade in various institutions across Europe, gathering immense expertise, Dr Camara has returned to Africa to contribute to its scientific advancement by developing a new clinical test to evaluate the efficacy of vaccines at an early stage and predict long-term protection.</p><p>His research focuses on understanding the mechanisms underlying the generation of long-lived plasma cells, antibody-secreting cells and their potential to be early predictors of vaccination success. He is particularly interested in malaria, a disease endemic to many African countries, and the efficacy of newly introduced malaria vaccines. Beyond malaria, he is also investigating vaccines that provide long-term or lifelong immunity, aiming to contribute to improved vaccine design and implementation strategies.</p><p><a href="https://www.malariavaccine.org/tools-resources/malaria-parasite-life-cycle" rel="noopener noreferrer" target="_blank">Malaria life cycle: Reproduced from PATH's Malaria Vaccines website at www.malariavaccine.org, 2024</a></p><p><a href="https://www.who.int/teams/global-malaria-programme/elimination#:~:text=As%20of%20January%202025%2C%20a,as%20malaria%2Dfree%20by%20WHO" rel="noopener noreferrer" target="_blank">Global Malaria programme</a></p><p><strong>WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – </strong></p><p>Visit the Microbe Mail <a href="https://microbemail.captivate.fm/" rel="noopener noreferrer" target="_blank">website</a> to sign up for updates </p><p><strong>Follow on</strong>:</p><p><u>Instagram</u>: <a href="https://www.instagram.com/microbe_mail?igsh=MWo4NGVpcDJ4d3M2Zw==" rel="noopener noreferrer" target="_blank">Microbe_Mail</a></p><p><u>X/Twitter</u>: <a href="https://x.com/microbemail?t=DBBAVuqPh9bh7VhrVpKJwA&s=09" rel="noopener noreferrer" target="_blank">@microbemail</a></p><p><u>Facebook</u>: <a href="https://www.facebook.com/microbemail?mibextid=ZbWKwL" rel="noopener noreferrer" target="_blank">MicrobeMail</a></p><p><u>Tiktok:</u> <a href="mailto:https://www.tiktok.com/@microbe.mail?_t=8k6FtWzw2uj&_r=1" rel="noopener noreferrer" target="_blank">@</a><a href="https://vm.tiktok.com/ZMMehs22o/" rel="noopener noreferrer" target="_blank">microbe.mail</a></p><p>Watch this episode on our new <u>YouTube channel</u>: <a href="https://www.youtube.com/@Microbe_mail-YT" rel="noopener noreferrer" target="_blank">Microbe Mail</a></p><p>E-mail us: <a href="mailto:[email protected]" rel="noopener noreferrer" target="_blank">[email protected]</a></p>
April 1, 2025
<p>Antimicrobial resistance has become one of healthcare's biggest challenges, and in the fight against AMR getting the right drug, the right dose, right indication and the right route is everything. In this episode, we’re exploring the critical role clinical pharmacists play in antimicrobial stewardship (AMS). Join Nonks, the latest microbe messenger to take the mic, as she talks to seasoned clinical pharmacist <strong>Ama Annor</strong>.</p><p>About our Guest: </p><p class="ql-align-justify"><strong>Ama Sakoa Annor</strong>, is a committed and proactive pharmacist who is trained in comprehensive pharmaceutical care for paediatric patients. She holds an MSc (Med) in Clinical Pharmacy and a DPharm Candidate with six publications.</p><p class="ql-align-justify">She is currently working at Dr George Mukhari Academic Hospital as a ward pharmacist, stationed in the paediatric medical and surgical departments. She is a member of the hospital’s Pharmacy and Therapeutics, AMS, ADR Committee and other sub-committees.</p><p class="ql-align-justify">She is also affiliated as a mentor with the Clinical Pharmacy Division of the School of Pharmacy of the Sefako Makgatho Health Sciences University. </p><p class="ql-align-justify">She has a passion for rational antimicrobial use and is privileged to be one of the mentees in the Ohio State University/Nationwide Children's Hospital - South Africa Train-the-Trainer program in the Neonatal Antimicrobial Stewardship Program in 2019. Two of the end products are the recent publications: </p><p class="ql-align-justify"><a href="https://doi.org/10.1016/j.ijid.2024.107158" rel="noopener noreferrer" target="_blank">“Prospective antimicrobial stewardship interventions by multidisciplinary teams to reduce neonatal antibiotic use in South Africa: the Neonatal Antimicrobial Stewardship (NeoAMS) study”. International Journal of Infectious Diseases 2024-06 | Journal article. </a>https://doi.org/10.1016/j.ijid.2024.107158</p><p class="ql-align-justify"><a href="https://doi.org/10.1093/jacamr/dlae222" rel="noopener noreferrer" target="_blank">“Defining and responding to the contextual drivers for implementation of antimicrobial stewardship in 14 neonatal units in South Africa”; JAC-Antimicrobial Resistance 2025 Vol. 7 Issue 1 </a> </p><p class="ql-align-justify"><a href="https://doi.org/10.1093/jacamr/dlae222" rel="noopener noreferrer" target="_blank">https://doi.org/10.1093/jacamr/dlae222</a></p><p class="ql-align-justify">Facebook: Ama Sakoa Annor</p><p class="ql-align-justify">Linkedin_ama_sakoa-annor</p><p class="ql-align-justify">X: @ama_sakoa_annor</p><p class="ql-align-justify">Instagram: amasakoa</p><p>Also listen to this: <strong>Episode 6: A is for antimicrobial stewardship</strong></p><p><strong>WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – </strong> </p><p>Visit the Microbe Mail <a href="https://microbemail.captivate.fm/" rel="noopener noreferrer" target="_blank">website</a> to sign up for updates </p><p>Follow on:</p><p><u>Instagram</u>: <a href="https://www.instagram.com/microbe_mail?igsh=MWo4NGVpcDJ4d3M2Zw==" rel="noopener noreferrer" target="_blank">Microbe_Mail</a></p><p><u>X/Twitter</u>: <a href="https://x.com/microbemail?t=DBBAVuqPh9bh7VhrVpKJwA&s=09" rel="noopener noreferrer" target="_blank">@microbemail</a></p><p><u>Facebook</u>: <a href="https://www.facebook.com/microbemail?mibextid=ZbWKwL" rel="noopener noreferrer" target="_blank">MicrobeMail</a></p><p><u>Tiktok:</u> <a href="mailto:https://www.tiktok.com/@microbe.mail?_t=8k6FtWzw2uj&_r=1" rel="noopener noreferrer" target="_blank">@</a><a href="https://vm.tiktok.com/ZMMehs22o/" rel="noopener noreferrer" target="_blank">microbe.mail</a></p><p>Watch this episode on our new <u>YouTube channel</u>: <a href="https://www.youtube.com/@Microbe_mail-YT" rel="noopener noreferrer" target="_blank">Microbe Mail</a></p><p>E-mail us: <a href="mailto:[email protected]" rel="noopener noreferrer"
Sara Dong
Society of Infectious Diseases Pharmacists
Vincent Racaniello
Infectious Disease: Insights of Two Specialists
JAMA Network
The Clinical Problem Solvers
Orthobullets
The Curbsiders Internal Medicine Podcast
Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist
Core IM Team
Thomas Watchman
Adam Thomas & Josh Farkas
American College of Physicians
Vincent Racaniello
BMJ Group
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.